Jakob K. Haaber
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
First-in-Human Adjunctive Bacteriophage Therapy for Malakoplakia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 10, 2026
Addressing the Research and Development Gaps in Modern Phage Therapy.
Journal: PHAGE (New Rochelle, N.Y.)
Published: March 21, 2025
Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study.
Journal: The Lancet. Microbe
Published: September 27, 2024
Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.
Journal: Nature biotechnology
Published: May 31, 2022
Bacteriophages benefit from generalized transduction.
Journal: PLoS pathogens
Published: March 31, 2019
Staphylococcus aureus coagulases are exploitable yet stable public goods in clinically relevant conditions.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 23, 2018
Commercial Biocides Induce Transfer of Prophage Φ13 from Human Strains of Staphylococcus aureus to Livestock CC398.
Journal: Frontiers in microbiology
Published: September 28, 2017
Aggregating resistant Staphylococcus aureus induces hypocoagulability, hyperfibrinolysis, phagocytosis, and neutrophil, monocyte, and lymphocyte binding in canine whole blood.
Journal: Veterinary clinical pathology
Published: August 01, 2017
Transfer of Antibiotic Resistance in Staphylococcus aureus.
Journal: Trends in microbiology
Published: March 27, 2017
Genome-Wide Identification of Antimicrobial Intrinsic Resistance Determinants in Staphylococcus aureus.
Journal: Frontiers in microbiology
Published: October 06, 2016
Last Updated: 09/26/2026